Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Retatrutide for Sale > Retatrutide | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder
Retatrutide  | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - large image1
Retatrutide  | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image1
Retatrutide  | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image2
Retatrutide  | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image3
Retatrutide  | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image4
Retatrutide  | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image5
Retatrutide  | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image6

Retatrutide | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder

6837 Inquiries

Unit Price:

$44-50/G FOB

Get Latest Price
CAS No.:

2381089-83-2

Content:

99%

Port:

Hong Kong

Packaging:

Vial/Bottle/Bag/Carton

Price valid (until):

2026-09-21

Company Type:
Trader
Location:
China
Qualification:
Main Products:

PEPTIDES

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Sales manager:Mika
    whatsapp:+447858195534


    Product Name Retatrutide
    Type Lyophilized Powder
    storage keep in a cool,dark location in a tightly sealed container or cylinder.
    CAS No 2381089-83-2
    Purity >99%
    Specific 5mg 10mg 15mg 20mg 30mg 40mg 60mg 1g
    Package 10 vials/box/kit


    What is Retatrutide?
    Retatrutide is a triple glucagon, GIP, and receptor agonist. Retatrutide showed glucose control and weight loss in patients with type 2 diabetes mellitus (T2DM).Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor .Retatrutide can be used for the research of obesity.Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual:Handling and Storage of Synthetic Peptides.Retatrutide is a new weight loss drug being experimented on by Eli Lilly, a pharmaceutical giant renowned for its breakthrough in diabetes and obesity treatment. Much like other weight loss drugs rolled out by Eli Lilly, Retatrutide is administered under the skin (subcutaneous route) per week and has yielded exceptional results in treating chronic diseases like diabetes and obesity compared to the predecessors.
     Function
    1.Treatment of depression and anxiety disorders: Retatrutide has been shown to have antidepressant and anxiolytic effects in preclinical studies, suggesting that it could be a promising treatment option for individuals with these conditions.
    2.Prevention of neurodegenerative diseases: Retatrutide has neuroprotective properties that may be useful in preventing or slowing the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.
    3.Enhancement of cognitive function: Retatrutide has been shown to improve learning and memory in animal studies, suggesting that it could have potential as a cognitive enhancer in humans.
    4.Treatment of chronic pain: Retatrutide has been shown to have analgesic effects in preclinical studies, suggesting that it could be a useful treatment option for individuals with chronic pain conditions.
    5.Promotion of wound healing: Retatrutide has been shown to accelerate wound healing in animal studies, suggesting that it could have potential as a therapeutic agent for promoting wound healing in humans.
    Application
    1.Retatrutide is often used in the pharmaceutical industry, weight losing, etc.
    2.Retatrutide is a kind of peptide product.
    3.Retatrutide acetate can inhibited GCGR, GIPR and GLP-1R.
    4.Retatrutide acetate is activated by glucagon receptors resulting in significant weight loss and increased energy expenditure.
    5.Retatrutide acetate can be used in studies of obesity.

    Shop Retatrutide  | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 1
    Shop Retatrutide  | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 2
    Shop Retatrutide  | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 3
    Shop Retatrutide  | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 4

    Shop Retatrutide  | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 5 Shop Retatrutide  | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 6 Shop Retatrutide  | 99% Purity | 5mg 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 7



      FAQ


    1. How to make an order?
    Send me message and let me know what you need with quantity , then i will calculate to you.

    2. What's the lead time and shipping ways?
    We will delivery to the package by USPS, FEDEX, DHL paket and UPS express to you after receive your payment, it would take around 5-15 days to your address.

    3. How do i keep the peptides when i receive it ?
    Peptides in the form of lyophilized powder can be transported at room temperature by vacuum packaging, while polypeptides in the dissolved state need to be refrigerated at 2°C - 8°C. For long-term storage, peptides should be stored in the form of lyophilized powder store at -20°C or -80°C in a sealed container with desiccant, which can avoid the degradation of peptides to the greatest extent.

    4. What's the payment methods ?
    We could accept pay through paypal,bank transfer and bitcoin.

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Polypeptide

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    PEPTIDES

    Location:

    Room 305, 3rd Floor, Unit 2, Building 48, Datangxia Zone 2, Choucheng Subdistrict, Yiwu, Jinhua, Zhejiang Province, China

    Year of Establishment:

    2026

  • Inquiry History
    6837 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.